{"filing":{"accession_number":"0001193125-26-272388","cik":"0000818033","ticker":"HRTX","company_name":"HERON THERAPEUTICS, INC. /DE/","form":"8-K","filing_date":"2026-06-16","report_date":null,"primary_document":"hrtx-20260611.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/818033/000119312526272388/hrtx-20260611.htm"},"events":[{"id":11267,"run_id":9885,"accession_number":"0001193125-26-272388","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"This Item 5.07 disclosure reports the results of Heron Therapeutics' 2026 Annual Meeting of Stockholders held on June 11, 2026, including voting outcomes on six proposals: director elections, auditor ratification, say-on-pay advisory vote, equity plan amendments, ESPP plan amendment, and Tax Benefits Preservation Plan ratification. The detailed vote tallies for each proposal are the core content of the filing, which is the standard form and substance of shareholder vote results disclosures.","company_name":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","filing_date":"2026-06-16","form":"8-K","submitted_at":null,"items":[{"id":7816,"accession_number":"0001193125-26-272388","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Heron Therapeutics' 2026 Annual Meeting of Stockholders held on June 11, 2026, including voting outcomes on six proposals: director elections, auditor ratification, say-on-pay advisory vote, equity plan amendments, ESPP plan amendment, and Tax Benefits Preservation Plan ratification. The detailed vote tallies for each proposal are the core content of the filing, which is the standard form and substance of shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T18:50:06.799949+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":7816,"accession_number":"0001193125-26-272388","item_number":"5.07","item_title":"Submission of Matters to a Vote of Security Holders.","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"This Item 5.07 disclosure reports the results of Heron Therapeutics' 2026 Annual Meeting of Stockholders held on June 11, 2026, including voting outcomes on six proposals: director elections, auditor ratification, say-on-pay advisory vote, equity plan amendments, ESPP plan amendment, and Tax Benefits Preservation Plan ratification. The detailed vote tallies for each proposal are the core content of the filing, which is the standard form and substance of shareholder vote results disclosures.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-16T18:50:06.799949+00:00","company_name":"HERON THERAPEUTICS, INC. /DE/","ticker":"HRTX","filing_date":"2026-06-16"}]}